Within the AD continuum, CSF 14–3-3 zeta/delta protein (ζ/δ) levels rise in subjects with Aβ deposition and early tau pathology, correlating primarily with neurodegeneration and memory function in cognitively unimpaired individuals. Here, MAPT is linked to Alzheimer disease.